Aristotle University Of Thessaloniki (AUTH)
Σιδηροπενία και αρρυθμιολογικό φορτίο σε ασθενείς με καρδιακή ανεπάρκεια
Abstract
dc:descriptionIron deficiency (ID) is a damaging condition for the cardiomyocyte, affecting its metabolic function, as iron is a key structural component of oxidative phosphorylation enzymes. In conditions of ID, an increase in glycolysis is observed at the cellular level, which leads to an increase in oxygen free radicals and, consequently, to increased oxidative stress, which ultimately causes electrochemical instability of the cell. ID is particularly common in patients with heart failure (HF), with a prevalence of around 40-50%. The aim of this doctoral thesis is to study, at a clinical level, the effect of ID on the arrhythmological burden of patients with HF with reduced ejection fraction (HFrEF). For this purpose, a prospective single-center follow-up study of patients with HFrEF and an implanted pacemaker or defibrillator, who suffered from ID and were treated with ferric carboxymaltose (FCM) was performed. A total of 96 patients with a median age of 71.9 (12.3) years were included, of whom 83% were male. Although visits were initially planned at 0, 3, 6 and 12 months of follow-up, due to the COVID-19 pandemic, emphasis was placed on visits at 0 and 12 months. Endpoints were ventricular arrhythmias recorded by the implanted pacemaker and defibrillator devices, non-invasive electrocardiographic arrhythmic markers from 24-hour and special 40-minute Holter recordings. In addition, hospitalizations, 6-minute walk test, left ventricular ejection fraction (LVEF), left ventricular strain, and quality of life of the patients were recorded. All patients were on optimal medication before their inclusion in the study. At 12 months, a statistically significant reduction in the frequency of ventricular tachyarrhythmia was observed (P=0.043 for ventricular tachycardia or fibrillation and P<0.0001 for persistent ventricular tachycardia). The classification of premature ventricular contractions by Holter, according to the Lown and Wolf classification, was the one that predicted with the greatest accuracy the presence of ventricular arrhythmia episodes (AUC 0.737, P=0.001), also showing a statistically significant improvement (P=0.002). Finally, other non-invasive arrhythmic markers, including late potentials, T-wave alternans and heart rate tubulence, as well as hospitalizations, NT-proBNP, LVEF, quality of life and maximal oxygen consumption in ergospirometry, showed statistically significant improvement (P<0.001) at 12 months after the administration of FCM. In summary, the present thesis is the first study to show the beneficial effect of treating ID in patients with HFrEF with intravenous FCM on the arrhythmic burden of the patients. However, larger double-blind randomized studies are necessary to investigate any possible causal relationship between ID and the occurrence of arrhythmias.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mouselimis, Dimitrios
- Μουσελίμης, Δημήτριος
Subjects
dc:subject × 14- Καρδιακή ανεπάρκεια
- Σιδηρούχος καρβοξυμαλτόζη
- Σιδηροπενία
- Αρρυθμιολογικό φορτίο
- Arrhythmic burden
- Heart failure
- Ferric carboxymaltose
- Iron deficiency
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Καρδιολογία και Καρδιοαγγειακά νοσήματα
- Clinical Medicine
- Medical and Health Sciences
- Cardiology and Cardiovascular Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58603